Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition

Background. Currently, overall survival rate for pediatric patients with acute myeloid leukemia (AML) do not exceed 70 %. The intensity of modern AML chemotherapeutic programs has reached its limit, and further chemotherapy dose escalation for treatment results improvement is impossible, because it...

Full description

Bibliographic Details

Published in:	Онкогематология
Main Authors:	V. S. Nemirovchenko, M. A. Shervashidze, T. T. Valiev, K. L. Kondratchik
Format:	Article
Language:	Russian
Published:	ABV-press 2020-07-01
Subjects:	acute myeloid leukemia chemotherapy epigenetic therapy treatment children
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/415